Original Research
Published on 12 Jan 2024
Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial
in Cytokines and Soluble Mediators in Immunity
- 1,566 views
Original Research
Published on 12 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Technology and Code
Published on 11 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 10 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 09 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Mini Review
Published on 08 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Mini Review
Published on 08 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Review
Published on 04 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 03 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Review
Published on 03 Jan 2024
in Cytokines and Soluble Mediators in Immunity
Review
Published on 18 Dec 2023
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 14 Dec 2023
in Cytokines and Soluble Mediators in Immunity
Mini Review
Published on 14 Dec 2023
in Cytokines and Soluble Mediators in Immunity
Review
Published on 13 Dec 2023
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 13 Dec 2023
in Cytokines and Soluble Mediators in Immunity
Mini Review
Published on 01 Dec 2023
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 30 Nov 2023
in Cytokines and Soluble Mediators in Immunity